These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 875626)

  • 1. Effects of delta9-tetrahydrocannabinol on the disposition of d-amphetamine in the rat.
    Siemens AJ
    Life Sci; 1977 Jun; 20(11):1891-904. PubMed ID: 875626
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
    Gorriti MA; Rodríguez de Fonseca F; Navarro M; Palomo T
    Eur J Pharmacol; 1999 Jan; 365(2-3):133-42. PubMed ID: 9988095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 1-delta9-tetrahydrocannabinol, dl-amphetamine and pentobarbital on oxygen consumption by mouse brain and heart homogenates.
    Dembert ML; Harclerode J
    Biochem Pharmacol; 1974 Mar; 23(5):947-56. PubMed ID: 4458679
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
    Lamb RJ; Järbe TU; Makriyannis A; Lin S; Goutopoulos A
    Eur J Pharmacol; 2000 Jun; 398(2):251-8. PubMed ID: 10854837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).
    Järbe TU; Lamb RJ; Liu Q; Makriyannis A
    Psychopharmacology (Berl); 2006 Oct; 188(3):315-23. PubMed ID: 16953384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalepsy induced by intrastriatal injections of delta9-THC and 11-OH-delta9-THC in the rat.
    Gough AL; Olley JE
    Neuropharmacology; 1978 Feb; 17(2):137-44. PubMed ID: 565018
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
    Pryor GT; Husain S; Mitoma C
    Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of various psychoactive drugs on the in vivo metabolism of d-amphetamine in the rat.
    Lewander T
    Eur J Pharmacol; 1969 Apr; 6(1):38-44. PubMed ID: 5784646
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
    Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
    Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An attempt to correlate the development of tolerance to delta-9-tetrahydrocannabinol and d-amphetamine with their subcellular distribution in rat brain.
    Magour S; Coper H; Fähndrich C
    Pol J Pharmacol Pharm; 1976; 28(6):589-92. PubMed ID: 1012982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of delta9-tetrahydrocannabinol on serum thyroxine concentrations in the rat.
    Nazar B; Kairys DJ; Fowler R; Harclerode J
    J Pharm Pharmacol; 1977 Dec; 29(12):778-9. PubMed ID: 22633
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of delta9-tetrahydrocannabinol and cannabidiol on a Mg2+-ATPase of synaptic vesicles prepared from rat cerebral cortex.
    Gilbert JC; Pertwee RG; Wyllie MG
    Br J Pharmacol; 1977 Apr; 59(4):599-601. PubMed ID: 139957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antiulcer activity of delta9-tetrahydrocannabinol in the Shay rat test.
    Sofia RD; Diamantis W; Harrison JE; Melton J
    Pharmacology; 1978; 17(3):173-7. PubMed ID: 704660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
    Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
    Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of amphetamine elimination in dogs and swine.
    Baggot JD; Davis LE
    Biochem Pharmacol; 1972 Jul; 21(14):1967-76. PubMed ID: 4649345
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of delta9-tetrahydrocannabinol on active avoidance acquisition and passive avoidance retention in rats with amygdaloid lesions.
    Pandina RJ; Musty RE
    Pharmacology; 1975; 13(4):297-308. PubMed ID: 1187754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
    Consroe P; Jones B; Laird H
    Ann N Y Acad Sci; 1976; 281():198-211. PubMed ID: 798523
    [No Abstract]   [Full Text] [Related]  

  • 19. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
    Taylor DA; Fennessy MR
    Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.